{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T12:44:27Z","timestamp":1791377067143,"version":"4.3.2"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T00:00:00Z","timestamp":1706486400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004480","name":"Shanxi Province Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004480","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.biopha.2024.116223","type":"journal-article","created":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T00:17:35Z","timestamp":1707178655000},"page":"116223","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Serine protease inhibitor from the muscle larval Trichinella spiralis ameliorates non-alcoholic fatty liver disease in mice via anti-inflammatory properties and gut-liver crosstalk"],"prefix":"10.1016","volume":"172","author":[{"given":"Mingwei","family":"Tong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyu","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihui","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangrong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.biopha.2024.116223_bib1","doi-asserted-by":"crossref","first-page":"715","DOI":"10.4254\/wjh.v9.i16.715","article-title":"Non-alcoholic fatty liver disease: an expanded review","volume":"9","author":"Benedict","year":"2017","journal-title":"World J. Hepatol."},{"issue":"10290","key":"10.1016\/j.biopha.2024.116223_bib2","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.biopha.2024.116223_bib3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.7861\/clinmedicine.18-3-245","article-title":"Non-alcoholic fatty liver disease","volume":"18","author":"Maurice","year":"2018","journal-title":"Clin. Med."},{"issue":"12","key":"10.1016\/j.biopha.2024.116223_bib4","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/jama.2020.2298","article-title":"Nonalcoholic Steatohepatitis: a review","volume":"323","author":"Sheka","year":"2020","journal-title":"Jama"},{"issue":"1 Suppl","key":"10.1016\/j.biopha.2024.116223_bib5","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/j.jhep.2015.02.041","article-title":"Current efforts and trends in the treatment of NASH","volume":"62","author":"Ratziu","year":"2015","journal-title":"J. Hepatol."},{"issue":"22","key":"10.1016\/j.biopha.2024.116223_bib6","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/jama.2015.5370","article-title":"Nonalcoholic fatty liver disease: a systematic review","volume":"313","author":"Rinella","year":"2015","journal-title":"Jama"},{"issue":"7","key":"10.1016\/j.biopha.2024.116223_bib7","first-page":"412","article-title":"The role of the gut microbiota in NAFLD, nature reviews","volume":"13","author":"Leung","year":"2016","journal-title":"Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116223_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms9010199","article-title":"Fecal microbiota transplant from human to mice gives insights into the role of the gut microbiota in non-alcoholic fatty liver disease (NAFLD)","volume":"9","author":"Burz","year":"2021","journal-title":"Microorganisms"},{"issue":"5","key":"10.1016\/j.biopha.2024.116223_bib9","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.cmet.2020.10.015","article-title":"A universal gut-microbiome-derived signature predicts cirrhosis","volume":"32","author":"Oh","year":"2020","journal-title":"Cell Metab."},{"issue":"4","key":"10.1016\/j.biopha.2024.116223_bib10","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/gutjnl-2019-319664","article-title":"Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites","volume":"70","author":"Zhang","year":"2021","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.biopha.2024.116223_bib11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/ajcn\/nqz042","article-title":"Gut microbiome-targeted therapies in nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression","volume":"110","author":"Sharpton","year":"2019","journal-title":"Am. J. Clin. Nutr."},{"issue":"7","key":"10.1016\/j.biopha.2024.116223_bib12","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.14309\/ajg.0000000000000661","article-title":"Allogenic fecal microbiota transplantation in patients with nonalcoholic fatty liver disease improves abnormal small intestinal permeability: a randomized control trial","volume":"115","author":"Craven","year":"2020","journal-title":"Am. J. Gastroenterol."},{"issue":"12","key":"10.1016\/j.biopha.2024.116223_bib13","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1080\/10408398.2021.1966738","article-title":"Intestinal dysbiosis in nonalcoholic fatty liver disease (NAFLD): focusing on the gut-liver axis","volume":"63","author":"Han","year":"2023","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"3","key":"10.1016\/j.biopha.2024.116223_bib14","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The gut-liver axis in liver disease: pathophysiological basis for therapy","volume":"72","author":"Albillos","year":"2020","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116223_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/nu15030743","article-title":"Sulforaphane ameliorates nonalcoholic fatty liver disease induced by high-fat and high-fructose diet via LPS\/TLR4 in the gut-liver axis","volume":"15","author":"Xu","year":"2023","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.biopha.2024.116223_bib16","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/bph.14095","article-title":"Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non-alcoholic fatty liver disease","volume":"175","author":"Wang","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2024.116223_bib17","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.immuni.2017.11.015","article-title":"Recent advances in type-2-cell-mediated immunity: insights from helminth infection","volume":"47","author":"Harris","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.biopha.2024.116223_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.124649","article-title":"Helminth-derived biomacromolecules as therapeutic agents for treating inflammatory and infectious diseases: what lessons do we get from recent findings?","volume":"241","author":"Chakraborty","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116223_bib19","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2174\/1568008023340523","article-title":"The immune response to the parasitic nematode Trichinella and the ways to escape it. From experimental studies to implications for human infection, Current drug targets","volume":"2","author":"Bruschi","year":"2002","journal-title":"Immune, Endocr. Metab. Disord."},{"issue":"1","key":"10.1016\/j.biopha.2024.116223_bib20","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ijpara.2020.07.012","article-title":"Trichinella spiralis infection ameliorated diet-induced obesity model in mice","volume":"51","author":"Kang","year":"2021","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.biopha.2024.116223_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.109924","article-title":"The Trichinella spiralis-derived antigens alleviate HFD-induced obesity and inflammation in mice","volume":"117","author":"Tong","year":"2023","journal-title":"Int Immunopharmacol."},{"issue":"5","key":"10.1016\/j.biopha.2024.116223_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008508","article-title":"Harnessing helminth-driven immunoregulation in the search for novel therapeutic modalities","volume":"16","author":"Ryan","year":"2020","journal-title":"PLoS Pathog."},{"issue":"6","key":"10.1016\/j.biopha.2024.116223_bib23","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1017\/S0031182011002435","article-title":"Serine protease inhibitors of parasitic helminths","volume":"139","author":"Molehin","year":"2012","journal-title":"Parasitology"},{"key":"10.1016\/j.biopha.2024.116223_bib24","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.3389\/fmicb.2017.01834","article-title":"Recombinant Trichinella pseudospiralis serine protease inhibitors alter macrophage polarization in vitro","volume":"8","author":"Xu","year":"2017","journal-title":"Front. Microbiol."},{"issue":"5","key":"10.1016\/j.biopha.2024.116223_bib25","doi-asserted-by":"crossref","first-page":"963","DOI":"10.4049\/jimmunol.2000290","article-title":"The anti-inflammatory immune response in early Trichinella spiralis intestinal infection depends on serine protease inhibitor-mediated alternative activation of macrophages","volume":"206","author":"Xu","year":"2021","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116223_bib26","article-title":"Effect of T. spiralis serine protease inhibitors on TNBS-induced experimental colitis mediated by macrophages","volume":"10","author":"Xu","year":"2020","journal-title":"Sci. Rep."},{"issue":"5259","key":"10.1016\/j.biopha.2024.116223_bib27","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.biopha.2024.116223_bib28","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"N. Nonalcoholic Steatohepatitis clinical research, design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2024.116223_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.109924","article-title":"The Trichinella spiralis-derived antigens alleviate HFD-induced obesity and inflammation in mice","volume":"117","author":"Tong","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2024.116223_bib30","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.it.2018.02.007","article-title":"Origin and immunological functions of spleen stromal cells","volume":"39","author":"Golub","year":"2018","journal-title":"Trends Immunol."},{"issue":"7122","key":"10.1016\/j.biopha.2024.116223_bib31","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/4441022a","article-title":"Microbial ecology: human gut microbes associated with obesity","volume":"444","author":"Ley","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2024.116223_bib32","doi-asserted-by":"crossref","first-page":"7489","DOI":"10.1038\/ncomms8489","article-title":"Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota","volume":"6","author":"Chang","year":"2015","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.biopha.2024.116223_bib33","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jhep.2016.12.018","article-title":"HBV inhibits LPS-induced NLRP3 inflammasome activation and IL-1beta production via suppressing the NF-kappaB pathway and ROS production","volume":"66","author":"Yu","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2024.116223_bib34","doi-asserted-by":"crossref","first-page":"m4747","DOI":"10.1136\/bmj.m4747","article-title":"Management of non-alcoholic fatty liver disease","volume":"372","author":"Petroni","year":"2021","journal-title":"Bmj"},{"key":"10.1016\/j.biopha.2024.116223_bib35","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.phrs.2018.04.008","article-title":"Helminth infection in mice improves insulin sensitivity via modulation of gut microbiota and fatty acid metabolism","volume":"132","author":"Pace","year":"2018","journal-title":"Pharmacol. Res."},{"issue":"7","key":"10.1016\/j.biopha.2024.116223_bib36","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1096\/fj.14-266239","article-title":"Chronic helminth infection and helminth-derived egg antigens promote adipose tissue M2 macrophages and improve insulin sensitivity in obese mice","volume":"29","author":"Hussaarts","year":"2015","journal-title":"FASEB J.: Off. Publ. Fed. Am. Soc. Exp. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116223_bib37","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrendo.2015.189","article-title":"Regulation of metabolism by the innate immune system","volume":"12","author":"Lackey","year":"2016","journal-title":"Nat. Rev. Endocrinol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116223_bib38","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/imm.13190","article-title":"Regulatory T-cells in helminth infection: induction, function and therapeutic potential","volume":"160","author":"White","year":"2020","journal-title":"Immunology"},{"issue":"11","key":"10.1016\/j.biopha.2024.116223_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165916","article-title":"Anti-arthritic activity of and derived-antigens in adjuvant arthritis in rats: role of FOXP3 treg cells","volume":"11","author":"Eissa","year":"2016","journal-title":"PloS One"},{"issue":"6","key":"10.1016\/j.biopha.2024.116223_bib40","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.celrep.2019.09.068","article-title":"Hepatocytes delete regulatory T cells by enclysis, a CD4(+) T cell engulfment process","volume":"29","author":"Davies","year":"2019","journal-title":"Cell Rep."},{"issue":"4","key":"10.1016\/j.biopha.2024.116223_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006345","article-title":"IL-33\/ST2 pathway drives regulatory T cell dependent suppression of liver damage upon cytomegalovirus infection","volume":"13","author":"Popovic","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.biopha.2024.116223_bib42","doi-asserted-by":"crossref","first-page":"8560831","DOI":"10.1155\/2022\/8560831","article-title":"Inflammatory cytokines, adipocytokines, and Th17\/Treg balance in patients with nonalcoholic fatty liver disease following administration of Dahuang Zhechong pills","volume":"2022","author":"Duan","year":"2022","journal-title":"Genet. Res."},{"issue":"7593","key":"10.1016\/j.biopha.2024.116223_bib43","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nature16969","article-title":"NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis","volume":"531","author":"Ma","year":"2016","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.biopha.2024.116223_bib44","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ccell.2014.09.003","article-title":"Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes","volume":"26","author":"Wolf","year":"2014","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.biopha.2024.116223_bib45","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41577-019-0232-6","article-title":"T(reg) cell-based therapies: challenges and perspectives","volume":"20","author":"Raffin","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2024.116223_bib46","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.3389\/fimmu.2020.01711","article-title":"Adoptive cell transfer of regulatory T cells exacerbates hepatic steatosis in high-fat high-fructose diet-fed mice","volume":"11","author":"Van Herck","year":"2020","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.biopha.2024.116223_bib47","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1159\/000448401","article-title":"Filarial infection or antigen administration improves glucose tolerance in diet-induced obese mice","volume":"8","author":"Berbudi","year":"2016","journal-title":"J. innate Immun."},{"issue":"3","key":"10.1016\/j.biopha.2024.116223_bib48","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00394-017-1524-x","article-title":"Influence of gut microbiota on the development and progression of nonalcoholic steatohepatitis","volume":"57","author":"de Faria Ghetti","year":"2018","journal-title":"Eur. J. Nutr."},{"issue":"1","key":"10.1016\/j.biopha.2024.116223_bib49","article-title":"Western diet contributes to the pathogenesis of non-alcoholic steatohepatitis in male mice via remodeling gut microbiota and increasing production of 2-oleoylglycerol","volume":"14","author":"Yang","year":"2023","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.biopha.2024.116223_bib50","first-page":"719","article-title":"Gut microbiome, microbial metabolites and the development of NAFLD, Nature reviews","volume":"15","author":"Caussy","year":"2018","journal-title":"Gastroenterol. Hepatol."},{"issue":"16","key":"10.1016\/j.biopha.2024.116223_bib51","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.3748\/wjg.v26.i16.1901","article-title":"Therapeutic advances in non-alcoholic fatty liver disease: A microbiota-centered view","volume":"26","author":"Chen","year":"2020","journal-title":"World J. Gastroenterol."},{"issue":"7","key":"10.1016\/j.biopha.2024.116223_bib52","first-page":"397","article-title":"The gut-liver axis and the intersection with the microbiome, nature reviews","volume":"15","author":"Tripathi","year":"2018","journal-title":"Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.biopha.2024.116223_bib53","first-page":"373","article-title":"Therapeutic pipeline in nonalcoholic steatohepatitis, nature reviews","volume":"18","author":"Vuppalanchi","year":"2021","journal-title":"Gastroenterol. Hepatol."},{"issue":"Pt 8","key":"10.1016\/j.biopha.2024.116223_bib54","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1099\/ijs.0.65208-0","volume":"58","author":"Liu","year":"2008","journal-title":"Int. J. Syst. Evolut. Microbiol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116223_bib55","doi-asserted-by":"crossref","first-page":"G227","DOI":"10.1152\/ajpgi.00267.2012","article-title":"A novel mechanism for gut barrier dysfunction by dietary fat: epithelial disruption by hydrophobic bile acids","volume":"304","author":"Stenman","year":"2013","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"4","key":"10.1016\/j.biopha.2024.116223_bib56","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1499-3872(17)60019-5","article-title":"Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease","volume":"16","author":"Shen","year":"2017","journal-title":"Hepatobiliary Pancreat. Dis. INT.: HBPD INT"},{"key":"10.1016\/j.biopha.2024.116223_bib57","doi-asserted-by":"crossref","first-page":"7261619","DOI":"10.1155\/2018\/7261619","article-title":"Modulation of the gut microbiota in rats by Hugan Qingzhi tablets during the treatment of high-fat-diet-induced nonalcoholic fatty liver disease","volume":"2018","author":"Tang","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"2","key":"10.1016\/j.biopha.2024.116223_bib58","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1128\/JCM.02926-14","article-title":"Clinical and microbiological characteristics of Eggerthella lenta bacteremia","volume":"53","author":"Gardiner","year":"2015","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.biopha.2024.116223_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.541178","article-title":"Alterations of the gut microbiome composition and lipid metabolic profile in radiation enteritis","volume":"10","author":"Li","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.biopha.2024.116223_bib60","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ebiom.2017.01.019","article-title":"Microbiome remodeling via the montmorillonite adsorption-excretion axis prevents obesity-related metabolic disorders","volume":"16","author":"Xu","year":"2017","journal-title":"EBioMedicine"},{"issue":"9","key":"10.1016\/j.biopha.2024.116223_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/nu14091965","article-title":"Bifidobacterium animalis ssp. lactis MG741 reduces body weight and ameliorates nonalcoholic fatty liver disease via improving the gut permeability and amelioration of inflammatory cytokines","volume":"14","author":"Do","year":"2022","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.biopha.2024.116223_bib62","doi-asserted-by":"crossref","DOI":"10.1186\/s13568-020-01038-y","article-title":"Probiotic V9 attenuates hepatic steatosis and inflammation in rats with non-alcoholic fatty liver disease","volume":"10","author":"Yan","year":"2020","journal-title":"Amb. Express"},{"key":"10.1016\/j.biopha.2024.116223_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.773340","article-title":"Alleviates liver steatosis and steatohepatitis by increasing fibroblast growth factor 21 sensitivity","volume":"12","author":"Long","year":"2021","journal-title":"Front. Endocrinol."},{"issue":"22","key":"10.1016\/j.biopha.2024.116223_bib64","doi-asserted-by":"crossref","first-page":"9066","DOI":"10.1073\/pnas.1219451110","article-title":"Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity","volume":"110","author":"Everard","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.biopha.2024.116223_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/JME-16-0054","article-title":"Akkermansia muciniphila improves metabolic profiles by reducing inflammation in chow diet-fed mice","volume":"58","author":"Zhao","year":"2017","journal-title":"J. Mol. Endocrinol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116223_bib66","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.cmet.2019.08.002","article-title":"Gut microbiome-based metagenomic signature for non-invasive detection of advanced fibrosis in human nonalcoholic fatty liver disease","volume":"30","author":"Loomba","year":"2019","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.biopha.2024.116223_bib67","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2021.1927633","article-title":"Gut Akkermansia muciniphila ameliorates metabolic dysfunction-associated fatty liver disease by regulating the metabolism of L-aspartate via gut-liver axis","volume":"13","author":"Rao","year":"2021","journal-title":"Gut Microbes"},{"issue":"6","key":"10.1016\/j.biopha.2024.116223_bib68","doi-asserted-by":"crossref","DOI":"10.1128\/msphere.00851-21","article-title":"Muribaculaceae genomes assembled from metagenomes suggest genetic drivers of differential response to acarbose treatment in mice","volume":"6","author":"Smith","year":"2021","journal-title":"mSphere"},{"issue":"8","key":"10.1016\/j.biopha.2024.116223_bib69","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1007\/s11255-021-03056-6","article-title":"Characterization of the gut microbiota in hemodialysis patients with sarcopenia","volume":"54","author":"Zhou","year":"2022","journal-title":"Int. Urol. Nephrol."},{"issue":"4","key":"10.1016\/j.biopha.2024.116223_bib70","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jcmgh.2020.06.010","article-title":"Helminth-induced and Th2-dependent alterations of the gut microbiota attenuate obesity caused by high-fat diet","volume":"10","author":"Su","year":"2020","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"issue":"45","key":"10.1016\/j.biopha.2024.116223_bib71","doi-asserted-by":"crossref","first-page":"16795","DOI":"10.3748\/wjg.v20.i45.16795","article-title":"Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis","volume":"20","author":"Giannelli","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.biopha.2024.116223_bib72","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.2337\/db07-1403","article-title":"Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice","volume":"57","author":"Cani","year":"2008","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.biopha.2024.116223_bib73","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrmicro3089","article-title":"The gut microbiota and obesity: from correlation to causality","volume":"11","author":"Zhao","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116223_bib74","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/hep.26592","article-title":"NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice","volume":"59","author":"Wree","year":"2014","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.biopha.2024.116223_bib75","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/s41419-018-1004-0","article-title":"Taurine attenuates arsenic-induced pyroptosis and nonalcoholic steatohepatitis by inhibiting the autophagic-inflammasomal pathway","volume":"9","author":"Qiu","year":"2018","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.biopha.2024.116223_bib76","doi-asserted-by":"crossref","DOI":"10.1186\/s13071-023-05857-3","article-title":"Inhibition of GSDMD-mediated pyroptosis triggered by intervention contributes to the alleviation of DSS-induced ulcerative colitis in mice","volume":"16","author":"Ma","year":"2023","journal-title":"Parasites Vectors"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224001045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224001045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:45:10Z","timestamp":1760103910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224001045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":76,"alternative-id":["S0753332224001045"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116223","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serine protease inhibitor from the muscle larval Trichinella spiralis ameliorates non-alcoholic fatty liver disease in mice via anti-inflammatory properties and gut-liver crosstalk","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116223","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116223"}}